Pediatrix Medical Group, Inc. $MD Shares Purchased by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. boosted its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 814.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 594,351 shares of the company’s stock after acquiring an additional 529,367 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Pediatrix Medical Group were worth $12,713,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Victory Capital Management Inc. lifted its position in shares of Pediatrix Medical Group by 30.7% during the third quarter. Victory Capital Management Inc. now owns 4,126,207 shares of the company’s stock worth $69,114,000 after purchasing an additional 968,553 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Pediatrix Medical Group by 5.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,569,219 shares of the company’s stock valued at $76,349,000 after purchasing an additional 169,441 shares in the last quarter. American Century Companies Inc. increased its stake in Pediatrix Medical Group by 38.9% during the 3rd quarter. American Century Companies Inc. now owns 2,682,976 shares of the company’s stock worth $44,940,000 after buying an additional 751,109 shares during the period. Geode Capital Management LLC lifted its holdings in Pediatrix Medical Group by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 2,181,712 shares of the company’s stock worth $46,674,000 after buying an additional 14,421 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Pediatrix Medical Group by 7.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,552,585 shares of the company’s stock valued at $33,210,000 after buying an additional 105,345 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on MD. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Jefferies Financial Group restated a “buy” rating and set a $27.00 price objective on shares of Pediatrix Medical Group in a report on Monday, April 20th. Truist Financial increased their target price on Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research note on Monday, April 13th. UBS Group raised their price target on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 12th. Finally, Mizuho set a $24.00 price target on shares of Pediatrix Medical Group in a research note on Friday, May 8th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, Pediatrix Medical Group currently has an average rating of “Hold” and an average price target of $22.50.

Insiders Place Their Bets

In other Pediatrix Medical Group news, Director Shirley A. Weis sold 36,028 shares of the firm’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.80% of the stock is currently owned by company insiders.

Pediatrix Medical Group Stock Up 1.6%

Shares of NYSE:MD opened at $24.24 on Thursday. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of 11.77 and a beta of 0.69. Pediatrix Medical Group, Inc. has a 1-year low of $11.84 and a 1-year high of $24.99. The company’s fifty day moving average is $22.81 and its two-hundred day moving average is $21.71. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.33 and a current ratio of 1.33.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The company had revenue of $476.20 million for the quarter, compared to the consensus estimate of $465.83 million. During the same period last year, the firm posted $0.33 EPS. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. Equities analysts anticipate that Pediatrix Medical Group, Inc. will post 2.1 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.